Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Development of cellular immune response after infant Prevenar vaccinations
2008-004489-23Phase 4Completed
- Sponsor
- Intravacc
- Start
- Jul 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, single-arm trial of pneumococcal 7-valent conjugate vaccine in pneumococcal disease, sponsored by Intravacc. Primary endpoints: Development of cellular immune response and Development of humoral immune response. Started Jul 2008; status: completed.
02
Drugs
pneumococcal 7-valent conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on 2008-004489-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004489-23.